Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.

Neurocase - 1 Feb 2005

Schoonenboom S N M, Visser P J, Mulder C, Lindeboom J, Van Elk E J, Van Kamp G J, Scheltens P H

Abstract excerpt

The aim of the study was to compare clinical variables between MCI patients at different risk for Alzheimer's disease (AD) according to their biomarker profile. Fifty-four percent out of 39 MCI patients had a low Abeta42 and high tau in cerebrospinal fluid (CSF) (high-risk), 26% either a low CSF Abeta32 or high CSF tau (intermediate-risk) and 20% a normal CSF Abeta42 and tau (low-risk). Both high-and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid beta-Peptides
Share to Cognition Disorders
Share to Memory

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mental Status Schedule

Share to Neuropsychological Tests

Share to Problem Solving

Share to Statistics, Nonparametric

Share to tau Proteins

Source

Identifiers

PMID: 15804919
DOI: 10.1080/13554790490896785

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biomarker profiles and their relation to clinical variables in mild cognitive impairment.PMID 15804919Read ↗

Amyloid-beta and tau proteins as biochemical markers of Alzheimer's diseaseSemantic proximity Read ↗

Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.Semantic proximity Read ↗

The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.Semantic proximity Read ↗

Plasma biomarkers for mild cognitive impairment and Alzheimer's diseaseSemantic proximity Read ↗

Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias.Semantic proximity Read ↗

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings.Semantic proximity Read ↗

Risk factors and predictive models in the progression from MCI to Alzheimer’s diseaseSemantic proximity Read ↗

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.Semantic proximity Read ↗

Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.Semantic proximity Read ↗

Disentangling relationships between Alzheimer's disease plasma biomarkers and established biomarkers in patients of tertiary memory clinicsSemantic proximity Read ↗

Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.Semantic proximity Read ↗

A diagnostic scale for Alzheimer’s disease based on cerebrospinal fluid biomarker profilesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.